Draft Commercial Use Agreement V1C1 template

Adds specs/TargetRevenueCommercialUseAgreement-V1C1.md, the companion
agreement the License repeatedly refers to but never itself set terms
for: commercial entitlement grant, fees and explicit Development Credit
allocation, applicable monetization extensions, metering, audit rights,
term/termination (cross-referenced to License §7.2/§5.2 so a Commercial
Use Agreement termination can never revoke an already-converted Milestone
Release), and a real Section 9 implementing the informed-consent breach-
disclosure election that License §7.4 deferred here: opt-in named
disclosure vs. an anonymized default, a 10-business-day pre-publication
notice with a dispute window, and a data-protection carve-out.

Unlike the License, this Agreement had no dedicated prior-art research
pass (WP-0001 T01-T05 covered license models, terminology, patents,
contributor rights, and jurisdiction constraints, not commercial-agreement
drafting norms) — its preliminary notice says so explicitly, and Appendix A
leaves Section 13 (Indemnification) unwritten rather than guess at a
default carrying real financial exposure.

Corrects three prior references from the placeholder filename
"TRSL-CommercialUseAgreement-Draft.md" to the actual deliverable name, and
cross-references it from README, PRD, TSD, and SCOPE.

Co-Authored-By: Claude Sonnet 5 <noreply@anthropic.com>
This commit is contained in:
tegwick 2026-07-29 12:48:23 +02:00
parent c12a4043c4
commit 7b244df858
7 changed files with 235 additions and 3 deletions

View file

@ -258,9 +258,31 @@ default. This meaningfully reduces the License text's own legal exposure —
the open item shifts from "should the License name parties by default"
to "the Commercial Use Agreement template needs its own naming/consent/
data-protection clause," recommended as a future
`TRSL-CommercialUseAgreement-Draft.md` deliverable analogous to the CLA
`TargetRevenueCommercialUseAgreement-V1C1.md` deliverable analogous to the CLA
recommendation in `history/260729-TRSL-ContributorRights-Research.md` §6.
Propagated to `OpenQuestions-WorkingDefaults.md` Q12 item 5,
`specs/ProductRequirementsDocument.md` FR-10, and
`specs/TechnicalSpecificationDocument.md` §4.1. Still `todo` — ready for
continued human review.
Result 2026-07-29 (maintainer request): drafted
`specs/TargetRevenueCommercialUseAgreement-V1C1.md` — the companion
Commercial Use Agreement template the License repeatedly refers to but
does not itself set terms for. Written at the same operative-text quality
bar as the License (19 numbered sections + 3 Exhibits), including a real
§9 "Public Conformity Record; Breach Disclosure Election" clause
implementing the informed-consent naming mechanism this session's §7.4
revision deferred to this Agreement: an explicit opt-in election
(anonymized default vs. named), a 10-business-day pre-publication notice
with a dispute window for named disclosure, and a data-protection
carve-out. Unlike the License, this Agreement had **no** dedicated
prior-art research pass (WP-0001 T01T05 covered license models,
terminology, patents, contributor rights, and jurisdiction constraints —
not commercial-agreement drafting norms), so its preliminary notice
explicitly says every substantive clause is more provisional than the
License's, and Appendix A leaves Section 13 (Indemnification) entirely
unwritten rather than guess at a default with real financial exposure.
Cross-referenced from the License's own Appendix A item 10 (filename
corrected from the earlier "-Draft.md" placeholder name to match this
actual deliverable). Still `todo` — ready for human review alongside the
License.